Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Lycium barbarum polysaccharide inhibits Hcy-induced vascular smooth muscle cells migration and invasion via upregulation of KLF4
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 20 February 2026

Lycium barbarum polysaccharide inhibits Hcy-induced vascular smooth muscle cells migration and invasion via upregulation of KLF4

  • Xinpeng Ma1 na1,
  • Xiuyu Wang1 na1,
  • Tingrun Mo1,
  • Xing Ma1 &
  • …
  • Minghao Zhang1 

Scientific Reports , Article number:  (2026) Cite this article

  • 6 Accesses

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Cell biology
  • Medical research

Abstract

This study examined the potential protective effects of Lycium barbarum polysaccharide (LBP) in opposing homocysteine (Hcy)-triggered vascular smooth muscle cells (VSMCs) migration and invasion. Additionally, we examined how Krüppel-like factor 4 (KLF4) participates in the underlying molecular mechanism. Primary human umbilical vein VSMCs were treated with Hcy (100 µmol/L) and divided into five groups: Control, Hcy (100 µmol/L), Hcy + 400 mg/L LBP, Hcy + 600 mg/L LBP, Hcy + 800 mg/L LBP. Cell migration was assessed by scratch assay to screen the optimal drug intervention concentration. KLF4 expression was analyzed via Western blot. Subsequently, cells were treated with Hcy+KLF4 agonist (APTO-235, AP), Hcy+KLF4 inhibitor (Kenpaullone, Ken), and Hcy + LBP+AP. Cell migration and invasion capacities were assessed via scratch assay and Transwell invasion assay. In comparison to the Control group, Hcy notably promoted VSMC migration and invasion and downregulated KLF4 expression. Both the Hcy + 600 mg/L LBP group and the Hcy + AP group exhibited reduced migration/invasion (P < 0.01 vs. Hcy) and upregulated KLF4. Conversely, Hcy + Ken increased migration/invasion and suppressed KLF4. Notably, Hcy + LBP+AP showed the strongest inhibition of migration/invasion and the highest KLF4 upregulation (P < 0.01 vs. Hcy + AP or Hcy + 600 mg/L LBP). LBP inhibits Hcy-induced VSMCs migration and invasion by upregulating KLF4, with synergistic effects observed upon KLF4 agonist co-treatment.

Data availability

All data generated or analysed during this study are included in this published article and its supplementary information files.

References

  1. Meyer, G. R. Y.D.et al.Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets. Nat. Rev. Cardiol. 21 (5), 312–325 (2024).

    Google Scholar 

  2. You, Y. R. et al. Epigenetic modulation of Drp1-mediated mitochondrial fission by inhibition of S-adenosylhomocysteine hydrolase promotes vascular senescence and atherosclerosis. Redox Biol. 65, 102828 (2023).

    Google Scholar 

  3. Habib, S. S. et al. Homocysteine as a predictor and prognostic marker of atherosclerotic cardiovascular disease: a systematic review and meta-analysis. Eur. Rev. Med. Pharmacol. Sci. 27 (18), 8598–8608 (2023).

    Google Scholar 

  4. Huynh, D. T. N. & Heo, K. S.Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis. Arch. Pharm. Res. 44 (12), 1051–1061 (2021).

    Google Scholar 

  5. Sun, F. X., Zeng, Y. & Zhang, M. H. Changes in CTRP9 expression during homocysteine induced proliferation, migration, and phenotype transformation of vascular smooth muscle cells. J. Ningxia Med. Univ. 43 (11), 1115–1119 (2021).

    Google Scholar 

  6. He, Z. H., He, J. & Xie, K. P. KLF4 transcription factor in tumorigenesis. Cell. Death Discovery. 9 (1), 118 (2023).

    Google Scholar 

  7. Zhang, C. et al. LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4. Biomed. Pharmacother. 119, 109431 (2019).

    Google Scholar 

  8. Wang, Q. Z. al.KLF4 overexpression decreases the viability, invasion and migration of papillary thyroid cancer cells. Exp. Ther. Med. 18 (5), 3493–3501 (2019).

    Google Scholar 

  9. Tan, Y. L.et al.KLF4 regulates trophoblast function and associates with unexplained recurrent spontaneous abortion. J. Transl Med. 22 (1), 922 (2024).

    Google Scholar 

  10. Zhang, X. H. et al. KLF4-PFKFB3-driven glycolysis is essential for phenotypic switching of vascular smooth muscle cells. Commun. Biol. 5 (1), 1332 (2022).

    Google Scholar 

  11. Ma, X. et al. Screening of miRNAs related to Hcy promoting proliferation and migration of vascular smooth muscle cells. J. Ningxia Med. Univ. 46 (01), 7–14 (2024).

    Google Scholar 

  12. Zhu, S. et al. Lycium Barbarum polysaccharide protects HaCaT cells from PM2.5-induced apoptosis via inhibiting oxidative stress, ER stress and autophagy. Redox Rep. 27 (1), 32–44 (2022).

    Google Scholar 

  13. Zhou, B. J. et al. The Effect of Lycium Barbarum Polysaccharide on the Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis. J. Am. Nutr. Assoc. 41 (6), 618–626 (2022).

    Google Scholar 

  14. Zhu, Y. F., Zhao, Q. P. & Jiang, Y. D. Lycium barbarum polysaccharides attenuates high glucose-induced diabetic retinal angiogenesis by rescuing the expression of miR-15a-5p in RF/6A cells. J. Ethnopharmacol. 283, 114651–114662 (2022).

    Google Scholar 

  15. Hu, L. et al. Lycium barbarum polysaccharide alleviates atherosclerosis in mice by up regulating the expression of adiponectin. Drug Eval Stud. 40 (03), 292–299 (2017).

    Google Scholar 

  16. Wang, X. Y. et al. Proliferation, migration and phenotypic transformation of VSMC induced via Hcy related to up-expression of WWP2 and p-STAT3. Plos One. 19 (1), e0296359 (2024).

    Google Scholar 

  17. Wang, X. Y. et al. Hypermethylation of the CTRP9 promoter region promotes Hcy induced VSMC lipid deposition and foam cell formation via negatively regulating ER stress. Sci. Rep. 13, 19438 (2023).

    Google Scholar 

  18. Nakajima, W. et al. Krüppel-like factor 4 and its activator APTO-253 induce NOXA-mediated, p53-independent apoptosis in triple-negative breast cancer cells. Genes 12, 539 (2021).

    Google Scholar 

  19. Xue, J. J. et al. Puerarin attenuates myocardial ischemic injury and endoplasmic reticulum stress by upregulating the Mzb1 signal pathway. Front. Pharmacol. 15, 1442831 (2024).

    Google Scholar 

  20. Zhang, M. H. et al. MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K/Akt/mTOR pathway. Histochem. Cell. Biol. 153 (5), 357–366 (2020).

    Google Scholar 

  21. González-Lamuño, D. et al. Hyperhomocysteinemia in Adult Patients: A Treatable Metabolic Condition. Nutrients 16 (1), 135 (2023).

    Google Scholar 

  22. Zhang, S. et al. Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder. Mol. Med. 29, 73 (2023).

    Google Scholar 

  23. Fu, Z. Y. et al. Vascular smooth muscle cell metabolic reprogramming and phenotypic remodeling in atherosclerosis. Cell. Death Discov 30, (2025).

  24. Wang, X. Y. et al. Reduced C1q/Tumor Necrosis Factor Related Protein9 Expression Promotes Hcy-Induced VSMCs Migraation via Negative Regulating Endoplasmic Reticulum Stress. Am. J. Biomed. Sci. 19 (1), 33–38 (2023).

    Google Scholar 

  25. Meng, L. P. et al. Polyphenols and Polypeptides in Chinese Rice Wine Inhibit Homocysteine-induced Proliferation and Migration of Vascular Smooth Muscle Cells. J. Cardiovasc. Pharmacol. 67 (6), 482–490 (2016).

    Google Scholar 

  26. Bao, X. M. & Zheng, H. C. The effect and possible mechanism of homocysteine on the proliferation and migration ability of rat vascular smooth muscle cells. Shandong Med. J. 55 (44), 25–27 (2015).

    Google Scholar 

  27. Yang, C. et al. Role of Kruppel-like factor 4 in atherosclerosis. Clin. Chim. Acta. 512, 135–141 (2021).

    Google Scholar 

  28. Ai, S. F. et al. Research progress on pharmacological mechanisms of Lycium barbarum polysaccharides.Spec. Econ. Anim. Plant. 27 (09), 116–118 (2024).

    Google Scholar 

  29. Tian, X. J. et al. Extraction, Structural Characterization, and Biological Functions of Lycium Barbarum Polysaccharides: A Review. Biomolecules 9 (9), 389 (2019).

    Google Scholar 

  30. Li, Z. Y. et al. Lycium barbarum polysaccharide alleviates DSS-induced chronic ulcerative colitis by restoring intestinal barrier function and modulating gut microbiota. Ann. Med. 55 (2), 229023 (2023).

    Google Scholar 

  31. Qi, G. X. et al. Homocysteine mediates apoptosis of APOE–/– mouse cardiomyocytes through endoplasmic reticulum stress and the intervention effect of Lycium barbarum polysaccharides. J. Ningxia Med. Univ. 41 (02), 109–113 (2019).

    Google Scholar 

  32. Zhang, M. H. et al. Lycium barbarum polysaccharide protects against Homocysteine-induced Vascular smooth muscle cell proliferation and phenotypic transformation via PI3K/Akt pathway. J. Mol. Histol. 51 (6), 629–637 (2020).

    Google Scholar 

  33. Zhou, Z. et al. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature 7 (7597), 122–126 (2016).

    Google Scholar 

  34. Yan, Q. et al. Oncofetal proteins and cancer stem cells. Essays Biochem. 66 (4), 423–433 (2022).

    Google Scholar 

  35. Liao, X. et al. Krüppel-like factor 4 regulates macrophage polarization. J. Clin. Invest. 121 (7), 2736–2749 (2011).

    Google Scholar 

  36. Han, Z. et al. .HOXA1 participates in VSMC-to-macrophage-like cell transformation via regulation of NF-kappaB p65 and KLF4: a potential mechanism of atherosclerosis pathogenesis. Mol. Med. 29 (1), 104 (2023).

    Google Scholar 

  37. Niu, N. et al. Targeting Mechanosensitive Transcription Factors in Atherosclerosis. Trends Pharmacol. Sci. 40 (4), 253–266 (2019).

    Google Scholar 

  38. Huang, T. et al. Protective effects of KLF4 on blood-brain barrier and oxidative stress after cerebral ischemia-reperfusion in rats through the Nrf2/Trx1 pathway. Cytokine 169, 156288 (2023).

    Google Scholar 

  39. Zhao, Q. et al. Lycium Barbarum Polysaccharides Alleviate Hyperglycemia-Aggravated Cerebral Ischemia/Reperfusion Injury by Up‐Regulating Wnt/β‐Catenin Signaling. Adv. Ther. 8, e0045 (2025).

    Google Scholar 

  40. Qi, Y. et al. Effect of Lycium barbarum polysaccharides on cell signal transduction pathways. Biomed. Pharmacother. 147, 112620 (2022).

    Google Scholar 

  41. Gan, F. et al. Lycium barbarum polysaccharides improve CCl4-induced liver fibrosis, inflammatory response and TLRs/NF‐kB signaling pathway expression in wistar rats. Life Sci. 192, 205–212 (2018).

    Google Scholar 

  42. Niu, Z. et al. Inhibition of Iron Death by Lycium barbarum Polysaccharides Ameliorates Myocardial Injury in Sepsis: A Pharmacological Mechanism Study Based on the NRF2/HO-1 Pathway. Food Sci. Nutr. 13 (9), e70835 (2025).

    Google Scholar 

Download references

Acknowledgements

We thank the Key Laboratory of Metabolic Cardiovascular Diseases Research of National Health Commission and Ningxia Key Laboratory of Vascular Injury and Repair Research for providing experimental platforms and technical support.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by the Ningxia Natural Science Foundation Project (2024AAC03200), Scientific Research Project of Higher Education Institutions of the Department of Education of Ningxia Hui Autonomous Region (NYG2024116), Open competition mechanism to select the best candidates for key research projects of Ningxia Medical University (XJKF240312), Ningxia University Student Science and Technology Innovation Research Project in 2025 (S202510752020).

Author information

Author notes
  1. These authors contributed equally: Xinpeng Ma and Xiuyu Wang.

Authors and Affiliations

  1. Key Laboratory of Metabolic Cardiovascular Diseases Research of National Health Commission, Ningxia Key Laboratory of Vascular Injury and Repair Research, Ningxia Medical University, 1160 Shengli Street, Yinchuan, 750004, Ningxia, People’s Republic of China

    Xinpeng Ma, Xiuyu Wang, Tingrun Mo, Xing Ma & Minghao Zhang

Authors
  1. Xinpeng Ma
    View author publications

    Search author on:PubMed Google Scholar

  2. Xiuyu Wang
    View author publications

    Search author on:PubMed Google Scholar

  3. Tingrun Mo
    View author publications

    Search author on:PubMed Google Scholar

  4. Xing Ma
    View author publications

    Search author on:PubMed Google Scholar

  5. Minghao Zhang
    View author publications

    Search author on:PubMed Google Scholar

Contributions

Xinpeng Ma:Design and implementation of experiments, participation in manuscript writing and data analysis, and responsibility for the overall framework construction of the project.Xiuyu Wang:Co-designed experiments with XM, participated in manuscript writing and partial data analysis, with contributions equivalent to Xinpeng Ma. Tingrun MoResponsible for experimental data collection, assistance with partial experimental operations, and organization of original data records.Xing Ma:Independently completed data analysis and statistics, and performed data processing and visualization using software such as GraphPad Prism 10.0.Minghao Zhang:As the corresponding author, designed the experimental protocol and guided the overall research, wrote the main text of the manuscript, and coordinated manuscript submission and academic communication.Xinpeng Ma and Xiuyu Wang contributed equally to this work.Statement: All authors reviewed the manuscript, approved the final version for publication, and are responsible for the accuracy and integrity of the research content.

Corresponding author

Correspondence to Minghao Zhang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics statement

The study was approved by the Ethics Committee of Ningxia Medical University (2024-N184) and conducted by the Guide for the Care and Use of Laboratory Animals, and the reporting follows the recommendations in the ARRIVE guidelines.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, X., Wang, X., Mo, T. et al. Lycium barbarum polysaccharide inhibits Hcy-induced vascular smooth muscle cells migration and invasion via upregulation of KLF4. Sci Rep (2026). https://doi.org/10.1038/s41598-026-41087-0

Download citation

  • Received: 28 July 2025

  • Accepted: 17 February 2026

  • Published: 20 February 2026

  • DOI: https://doi.org/10.1038/s41598-026-41087-0

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Lycium barbarum polysaccharide
  • KLF4
  • Vascular smooth muscle cells
  • Hcy
  • Atherosclerosis
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing